发现人类AKT1基因有害的单核酸多态:一个体研究
Ruojun Zhang1, Nahid Akhtar2, Atif Khurshid Wani2
1School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Life (Basel, Switzerland)
|July 29, 2023
概括
这项研究确定了12种有害的AKT1基因突变,其中4种在保存残留物中,可能会影响蛋白质功能. 一种突变 (R273Q) 与肝癌有关,有助于疾病诊断和药物开发.
科学领域:
- 遗传学和分子生物学
- 生物信息学和计算生物学
背景情况:
- AKT1基因编码了一种对细胞亡,血管新生,新陈代谢和增殖至关重要的氨酸/氨酸激酶.
- AKT1基因突变与各种癌症和遗传疾病 (如蛋白质和考登综合征) 有关.
研究的目的:
- 在AKT1基因中识别有害的误解单核酸多态 (SNP).
- 使用计算工具预测这些AKT1SNP的功能和结构影响.
主要方法:
- 在人类AKT1基因的分析中,以确定有害的误解SNP.
- 评估SNP对AKT1蛋白结构和功能的影响.
- 对已识别的SNP与癌症类型之间的联系进行分析.
主要成果:
- 确定了12种高度有害的AKT1SNP,影响蛋白质结构和功能.
- 四个SNP (G157R,G159V,G336D,H265Y) 位于保存的残留物中.
- SNP G157R可能会影响联体结合;SNP R273Q与肝癌有关.
结论:
- 这些发现支持SNP识别和疾病关联研究的计算方法的实用性.
- 已识别的SNP可以为AKT1相关疾病的药物基因组学和分子诊断提供信息.
- 这项研究有助于开发AKT1瘤基因的向抑制剂.
相关概念视频
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


